Hi Terry,
Two things. 🙂
One in common with you re: the pulmonary embolism… I had one quite early in my journey, only four weeks or so after receiving high dose radiotherapy for a tumour on my spine (directly related or so I am told) of which I too was lucky to survive and received enoxaparin for 6 months, followed by Warfarin for 12 months followed by my Stem Cell Transplant (SCT) after which I was cleared of all treatment… until I developed a Deep Vein Thrombosis (DVT) last summer and was put back on enoxaparin.
The other was a near miss. That is I was put forward and accepted onto Onyx's 'Aspire' Carfilzomib trial in January this year, for 2 previously failed major treatments, in my case CDT, SCT & Velcade… but although I was accepted my urine needed to show 5% myeloma and despite 3 tries, 2 weeks apart, it failed to reach such dizzy heights before Aspire pulled the plug and declared the trial full and closed.
So the gamble of waiting for treatment to qualify for the treatment failed.. in a way… because even if I had qualified (all other qualifiers except for the urine were reached) I would still have to go through the randomisation of 50/50 selection for the Carfilzomib. The non-Carfilzomib arm of the trial was Revlimid and Dexamethasone… which was the next treatment lined up for me anyway.
So, I started on Rev & Dex on March 1st this year and I am currently on Cycle 3… after which, if it is deemed suitable, i.e. all bloods and levels okay, it will be my treatment for the foreseeable future.
I reported my efforts here and no-one came forward saying they were active on the trial but you never know… unfortunately we have new MMer's and people down the line, joining us every week, so you may well find someone coming forward.:-)
I hope they do.. and I hope the trial comes to you with no hold-ups or drawbacks. My consultant in Nottingham is very hopeful for Carfilzomib… and although I may have to wait a year… or two… so am I.;-)
Regards
Dai.